Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
May 5, 2020 8:13 AM 3 min read

National Healthcare Financing Company Protects Providers and Patients from Fraud with Intellicheck's Web and Mobile Person-Not-Present Authentication Tools

by Business Wire
Follow
IDN Logo
IDNIntellicheck Inc
$4.76-2.01%
Overview

The innovative healthcare financing organization makes medical procedures achievable for patients and supports healthcare providers' business goals by bridging the gap between the providers' medical offerings and the affordability of those services for patients.

Intellicheck's frictionless, real-time technology solutions allow companies to quickly and seamlessly respond to business and consumer financial services requests, while deterring losses associated with fraud. Quickly and easily implemented, the technology solutions provide a superior level of transaction and account fraud protection that is proven more than 99% effective.

About Intellicheck

View source version on businesswire.com: https://www.businesswire.com/news/home/20200505005142/en/

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Press Releases

A nationwide healthcare financing organization is using Intellicheck, Inc.'s (NASDAQ:IDN) web and mobile authentication tools to prevent fraud. The company is authenticating physicians' IDs as a critical first step in the finance organization's onboarding of new clients. They are also using the technology solutions to authenticate patient IDs for person-not-present financing applications.

This finance company's call center associates are using Intellicheck's no-integration web-based platform to authenticate person-not-present patients. For patients without a mobile phone, the company is using Intellicheck's downloadable mobile app to authenticate patient IDs that have been emailed or faxed. Both technology solutions are also being used to authenticate physicians' IDs as part of the firm's client onboarding process. The deployment of these tools allows the healthcare financing company to assure that the applicants, physicians and patients alike, are who they say they and will prevent criminals from fraudulently obtaining financing.

Intellicheck CEO Bryan Lewis said this represents an important milestone for the company, "Our authentication solutions are powerful fraud fighting tools that have been adopted by a number of top financial institutions nationwide. This new agreement is a notable step forward because it represents our entry into the healthcare market. We stop fraud for our clients both on-premise or person-not-present and across multiple delivery platforms"

Lewis said the diverse healthcare marketplace is a natural progression for the company and for healthcare financing providers and the doctors and patients they serve. "The healthcare industry is under attack. The deluge of stolen data from ongoing data breaches has shown a bright light on the growing need to combat spiraling fraudulent account take overs and new account openings. Our in-person and person-not-present ID authentication technologies provide immediate access to solutions that are both proven and affordable," explained Lewis.

Intellicheck (NASDAQ:IDN) is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. We make it possible for our clients to increase revenues, improve customer service, and increase operational efficiencies. The company is focused on partnering with banks, credit card issuers and retailers to prevent fraud. Intellicheck also serves law enforcement agencies, national defense clients and diverse state and federal government agencies. For more information on Intellicheck, visit us on the web and follow us on LinkedIn, Twitter, Facebook, and YouTube.

IDN Logo
IDNIntellicheck Inc
$4.76-2.01%
Overview
Comments
Loading...